Related Experiment Videos
Alterations of the central noradrenergic system in MPTP-induced monkey parkinsonism
1Third Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
Abstract:
Alterations of the coeruleo-cortical adrenergic system in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced monkey parkinsonism were examined through neuropathological observation and radioreceptor assay. Neuronal degeneration was found not only in the substantia nigra but also in the locus coeruleus of all the MPTP-treated monkeys. From radioreceptor assay, decreases of alpha 1 and alpha 2 receptors in the parietal and temporal cortices were observed in parkinsonian monkeys. In addition, beta receptors increased in the temporal cortex. These changes in monkey parkinsonism are very similar to those in human Parkinson's disease.
Insights
MPTP-induced parkinsonian monkeys showed neuronal degeneration in the substantia nigra and locus coeruleus. Adrenergic receptor changes in these monkeys closely mirror those seen in human Parkinson's disease.
Area of Science:
- Neuroscience
- Neuropathology
- Pharmacology
Background:
- Parkinson's disease is a neurodegenerative disorder affecting motor function.
- The coeruleo-cortical adrenergic system plays a role in neurological functions.
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin used to model parkinsonism in animals.
Purpose of the Study:
- To investigate alterations in the coeruleo-cortical adrenergic system in MPTP-induced monkey parkinsonism.
- To compare neuropathological and receptor binding changes in MPTP-treated monkeys with human Parkinson's disease.
Main Methods:
- Neuropathological examination of brain tissue from MPTP-treated monkeys.
- Radioreceptor assay to quantify adrenergic receptor levels in specific brain regions.
Main Results:
- MPTP treatment caused neuronal degeneration in both the substantia nigra and locus coeruleus.
- Decreased alpha 1 and alpha 2 adrenergic receptors were observed in the parietal and temporal cortices.
- An increase in beta adrenergic receptors was noted in the temporal cortex.
Conclusions:
- MPTP-induced monkey parkinsonism exhibits significant neuropathological changes in key brainstem nuclei.
- Adrenergic receptor alterations in the cortex of parkinsonian monkeys resemble those found in human Parkinson's disease.
- This model effectively replicates crucial aspects of the human disease, aiding further research.